Programming of deep brain stimulation of the centromedian nucleus of the thalamus for drug‐resistant epilepsy: A meta‐analysis and proposed programming framework
Epilepsia · 2026-11 · 67 (11) · 5811-5828
DOI: 10.1002/epi.70445 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Epilepsia, online erschienen am 22.08.2026. Verfasst von Mohammed A AlQahtani und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Boston Children's Hospital, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Deep Brain Stimulation, Drug Resistant Epilepsy, Intralaminar Thalamic Nuclei. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Objective
Although the centromedian nucleus of the thalamus (CM) is an increasingly considered deep brain stimulation (DBS) target for drug‐resistant epilepsy (DRE), there is significant variability in programming practices, which may contribute to heterogenous outcomes. We systematically described stimulation parameters for CM‐DBS and their association with seizure outcomes to inform a standardized, evidence‐informed programming framework.
Methods
We performed a Preferred Reporting Items for Systematic reviews and Meta‐Analysis (PRISMA)–guided systematic review and meta‐analysis of published studies pertaining to CM‐DBS including all dates through March 2026. Eligible studies included patients with DRE treated with CM‐DBS, extractable seizure outcomes, and reported stimulation parameters. Study‐level data and extractable patient‐level data were synthesized. The primary outcome was percent seizure reduction at the last follow‐up. Using random‐effects meta‐analysis we summarized study‐level efficacy and performed regression analyses to assess associations with diagnosis, seizure semiology, and stimulation parameters.
Results
Thirty studies including 269 individuals met inclusion criteria. Median seizure reduction was 71.5% and 200 participants (74.6%) with seizure outcome data were responders (>50% seizure reduction), which likely represents an upper bound on true efficacy given the predominance of non‐randomized studies at serious‐to‐critical risk of bias. Generalized tonic–clonic seizures were associated with greater seizure reduction. Tonic seizures were associated with worse outcome, yet this was attenuated after accounting for study clustering. Stimulation parameters varied substantially across studies. No single nominal stimulation parameter demonstrated a robust clinically actionable association with outcome; however, estimated total electrical energy delivered was associated with greater seizure reduction on multivariable modeling, yet this was attenuated when accounting for clustering between studies. Significance These findings map the landscape of programming of CM‐DBS, while emphasizing the need for standardized reporting of stimulation parameters, contact localization, and stimulation exposure to enable prospective optimization. On this basis, we propose a pragmatic, evidence‐informed programming framework for CM‐DBS that emphasizes postoperative contact localization, standardized initial stimulation settings, and stepwise titration of stimulation exposure.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, Boston Children's Hospital, Boston, Massachusetts, USA.
- Neuroscience Center, King Fahad Specialist Hospital, Dammam, Saudi Arabia.
- Division of Neurology, Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
- Edmond J. Safra Program in Parkinson's Disease, Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, UHN, Toronto, Ontario, Canada.
- Krembil Brain Institute, Toronto Western Hospital, Toronto, Ontario, Canada.
- Department of Surgery, University of Toronto, Toronto, Ontario, Canada.
ORCID-Profile: Mohammed A AlQahtani, Michal Stern-Zimmer, Puneet Jain, Alfonso Fasano, Alexander Rotenberg, George M Ibrahim
Zitieren
APA
AlQahtani, M. A., Stern-Zimmer, M., Jain, P., Sharma, S., Fasano, A., Rotenberg, A., Ibrahim, G. M., & Gorodetsky, C. (2026). Programming of deep brain stimulation of the centromedian nucleus of the thalamus for drug‐resistant epilepsy: A meta‐analysis and proposed programming framework. Epilepsia, 67(11), 5811-5828. https://doi.org/10.1002/epi.70445
Vancouver
AlQahtani MA, Stern-Zimmer M, Jain P, Sharma S, Fasano A, Rotenberg A, et al. Programming of deep brain stimulation of the centromedian nucleus of the thalamus for drug‐resistant epilepsy: A meta‐analysis and proposed programming framework. Epilepsia. 2026;67(11):5811-5828. doi:10.1002/epi.70445
BibTeX
@article{AlQahtani2026,
author = {AlQahtani, Mohammed A and Stern-Zimmer, Michal and Jain, Puneet and Sharma, Suvasini and Fasano, Alfonso and Rotenberg, Alexander and Ibrahim, George M and Gorodetsky, Carolina},
title = {Programming of deep brain stimulation of the centromedian nucleus of the thalamus for drug‐resistant epilepsy: A meta‐analysis and proposed programming framework},
journal = {Epilepsia},
year = {2026},
volume = {67},
number = {11},
pages = {5811--5828},
doi = {10.1002/epi.70445}
}
EUVIMED